P. Eggimann, J. Garbino, and D. Pittet, Epidemiology of Candida species infections in critically ill non-immunosuppressed patients, The Lancet Infectious Diseases, vol.3, issue.11, pp.685-702, 2003.
DOI : 10.1016/S1473-3099(03)00801-6

M. Pfaller, D. Diekema, and D. Gibbs, Results from the ARTEMIS DISK Global Antifungal Surveillance Study5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion, J Clin Microbiol, vol.10, issue.48, pp.1366-77, 1997.

D. Warnock, Trends in the Epidemiology of Invasive Fungal Infections, Nippon Ishinkin Gakkai Zasshi, vol.48, issue.1, pp.1-12, 2007.
DOI : 10.3314/jjmm.48.1

M. Pfaller and D. Diekema, Epidemiology of Invasive Mycoses in North America, Critical Reviews in Microbiology, vol.29, issue.6, pp.1-53, 2010.
DOI : 10.1128/JCM.41.11.5233-5235.2003

R. Hachem, H. Hanna, and D. Kontoyiannis, The changing epidemiology of invasive candidiasis, Cancer, vol.37, issue.11, pp.2493-2502, 2008.
DOI : 10.1002/cncr.23466

D. Horn, D. Neofytos, and E. Anaissie, Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry, Clinical Infectious Diseases, vol.48, issue.12, pp.1695-703, 2009.
DOI : 10.1086/599039

E. Van-asbeck, K. Clemons, and D. Stevens, Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility, Critical Reviews in Microbiology, vol.74, issue.1, pp.283-309, 2009.
DOI : 10.1080/00362178485380661

B. Almirante, D. Rodriguez, and M. Cuenca-estrella, Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003, Journal of Clinical Microbiology, vol.44, issue.5, pp.1681-1686, 2002.
DOI : 10.1128/JCM.44.5.1681-1685.2006

T. Zaoutis, J. Argon, and J. Chu, The Epidemiology and Attributable Outcomes of Candidemia in Adults and Children Hospitalized in the United States: A Propensity Analysis, Clinical Infectious Diseases, vol.41, issue.9, pp.1232-1241, 2005.
DOI : 10.1086/496922

L. Walker, N. Gow, and C. Munro, Fungal echinocandin resistance, Fungal Genetics and Biology, vol.47, issue.2, pp.117-143, 2010.
DOI : 10.1016/j.fgb.2009.09.003

D. Trofa, A. Gacser, and J. Nosanchuk, Candida parapsilosis, an Emerging Fungal Pathogen, Clinical Microbiology Reviews, vol.21, issue.4
DOI : 10.1128/CMR.00013-08

A. Tavanti, A. Davidson, and N. Gow, Candida orthopsilosis and Candida metapsilosis spp. nov. To Replace Candida parapsilosis Groups II and III, Journal of Clinical Microbiology, vol.43, issue.1, pp.284-92, 2005.
DOI : 10.1128/JCM.43.1.284-292.2005

S. Lockhart, S. Messer, and M. Pfaller, Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis, Journal of Clinical Microbiology, vol.46, issue.8, pp.2659-64, 2008.
DOI : 10.1128/JCM.00803-08

M. Horka, F. Ruzicka, and A. Kubesova, Separation of phenotypically indistinguishable Candida species, C. orthopsilosis, C. metapsilosis and C. parapsilosis, by capillary electromigration techniques, Journal of Chromatography A, vol.1218, issue.25, pp.3900-3907, 2011.
DOI : 10.1016/j.chroma.2011.04.057

A. Antoniadou, H. Torres, and R. Lewis, Candidemia in a Tertiary Care Cancer Center, Medicine, vol.82, issue.5, pp.309-330, 2003.
DOI : 10.1097/01.md.0000091182.93122.8e

P. Pappas, C. Kauffman, and D. Andes, Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-538, 2009.
DOI : 10.1086/596757

E. Bouza and P. Munoz, Epidemiology of candidemia in intensive care units, International Journal of Antimicrobial Agents, vol.32, issue.2, pp.87-91, 2008.
DOI : 10.1016/S0924-8579(08)70006-2

D. Pittet, M. Monod, and P. Suter, Candida Colonization and Subsequent Infections in Critically III Surgical Patients, Annals of Surgery, vol.220, issue.6, pp.751-759, 1994.
DOI : 10.1097/00000658-199412000-00008

P. Charles, F. Dalle, and A. H. , Candida spp. colonization significance in critically ill medical patients: a prospective study, Intensive Care Medicine, vol.36, issue.3, pp.393-400, 2005.
DOI : 10.1007/s00134-005-2571-y

C. Leon, S. Ruiz-santana, and P. Saavedra, A bedside scoring system (???Candida score???) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*, Critical Care Medicine, vol.34, issue.3, pp.730-737, 2006.
DOI : 10.1097/01.CCM.0000202208.37364.7D

C. Leon, S. Ruiz-santana, and P. Saavedra, Usefulness of the ???Candida score??? for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study, Critical Care Medicine, vol.37, issue.5, pp.1624-1657, 2009.
DOI : 10.1097/CCM.0b013e31819daa14

L. Ostrosky-zeichner, C. Sable, and J. Sobel, Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting, European Journal of Clinical Microbiology & Infectious Diseases, vol.31, issue.4, pp.271-277, 2007.
DOI : 10.1007/s10096-007-0270-z

E. Hermsen, M. Zapapas, and M. Maiefski, Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study, Critical Care, vol.15, issue.4, p.198, 2011.
DOI : 10.1089/109629600750067200

T. Kourkoumpetis, G. Velmahos, and P. Ziakas, The Effect of Cumulative Length of Hospital Stay on the Antifungal Resistance of Candida Strains Isolated from Critically Ill Surgical Patients, Mycopathologia, vol.45, issue.1, pp.85-91, 2011.
DOI : 10.1007/s11046-010-9369-3

D. Pauw, B. Walsh, T. Donnelly, and J. , Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clinical Infectious Diseases, vol.46, issue.12, pp.1813-1834, 2008.
DOI : 10.1086/588660

J. Peman and R. Zaragoza, Current diagnostic approaches to invasive candidiasis in critical care settings, Mycoses, vol.177, issue.Suppl. 3, pp.424-457, 2010.
DOI : 10.1111/j.1439-0507.2009.01732.x

F. Persat, S. Ranque, and F. Derouin, Contribution of the (1->3)-??-D-Glucan Assay for Diagnosis of Invasive Fungal Infections, Journal of Clinical Microbiology, vol.46, issue.3, pp.1009-1022, 2008.
DOI : 10.1128/JCM.02091-07

M. Ellis, B. Al-ramadi, and M. Finkelman, Assessment of the clinical utility of serial ??-D-glucan concentrations in patients with persistent neutropenic fever, Journal of Medical Microbiology, vol.57, issue.3, pp.287-95, 2008.
DOI : 10.1099/jmm.0.47479-0

L. Senn, J. Robinson, and S. Schmidt, 3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia, Clin Infect Dis, vol.1, issue.46, pp.878-85, 2008.

S. Kohno, K. Mitsutake, and S. Maesaki, An Evaluation of Serodiagnostic Tests in Patients with Candidemia: Beta-Glucan, Mannan, Candida Antigen by Cand-Tec and D-Arabinitol, Microbiology and Immunology, vol.32, issue.3
DOI : 10.1111/j.1348-0421.1993.tb03201.x

B. Atkinson, R. Lewis, and D. Kontoyiannis, fungemia in cancer patients: risk factors for amphotericin B failure and outcome, Medical Mycology, vol.46, issue.6, pp.541-547, 2008.
DOI : 10.1080/13693780801968571

J. Dick, B. Rosengard, and W. Merz, Fatal Disseminated Candidiasis Due to Amphotericin-B-Resistant Candida guilliermondii, Annals of Internal Medicine, vol.102, issue.1, pp.67-75, 1985.
DOI : 10.7326/0003-4819-102-1-67

A. Colombo, A. Melo, C. Rosas, and R. , Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy, Diagnostic Microbiology and Infectious Disease, vol.46, issue.4, pp.253-260, 2003.
DOI : 10.1016/S0732-8893(03)00079-8

D. Sanglard and F. Odds, Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences, The Lancet Infectious Diseases, vol.2, issue.2, pp.73-85, 2002.
DOI : 10.1016/S1473-3099(02)00181-0

P. Vandeputte, G. Tronchin, and G. Larcher, A Nonsense Mutation in the ERG6 Gene Leads to Reduced Susceptibility to Polyenes in a Clinical Isolate of Candida glabrata, Antimicrobial Agents and Chemotherapy, vol.52, issue.10, pp.3701-3710, 2008.
DOI : 10.1128/AAC.00423-08

URL : https://hal.archives-ouvertes.fr/hal-00492362

E. Eucast, Definitive Document EDef 7.1:Method for the determination of broth dilution MIC's of antifungal agents for fermentative yeasts, Clin Microbiol Infect, vol.14, pp.398-405, 2008.

M. Pfaller, S. Messer, and A. Bolmstrom, Evaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin B, Diagnostic Microbiology and Infectious Disease, vol.32, issue.3, pp.223-230, 1998.
DOI : 10.1016/S0732-8893(98)00120-5

J. Rex, M. Pfaller, and J. Galgiani, Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections, Clinical Infectious Diseases, vol.24, issue.2, pp.235-282, 1997.
DOI : 10.1093/clinids/24.2.235

J. Rex and M. Pfaller, Has Antifungal Susceptibility Testing Come of Age?, Clinical Infectious Diseases, vol.35, issue.8, pp.982-991, 2002.
DOI : 10.1086/342384

D. Sanglard, F. Ischer, and M. Monod, Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene, Microbiology, vol.143, issue.2, pp.405-421, 1997.
DOI : 10.1099/00221287-143-2-405

P. Mukherjee and J. Chandra, biofilm resistance, Drug Resistance Updates, vol.7, issue.4-5, pp.301-310, 2004.
DOI : 10.1016/j.drup.2004.09.002

A. Zimbeck, N. Iqbal, and A. Ahlquist, FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance, Antimicrobial Agents and Chemotherapy, vol.54, issue.12, pp.5042-5049, 2010.
DOI : 10.1128/AAC.00836-10

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981257

P. Vandeputte, G. Tronchin, and T. Berges, Reduced Susceptibility to Polyenes Associated with a Missense Mutation in the ERG6 Gene in a Clinical Isolate of Candida glabrata with Pseudohyphal Growth, Antimicrobial Agents and Chemotherapy, vol.51, issue.3, pp.982-90, 2007.
DOI : 10.1128/AAC.01510-06

URL : https://hal.archives-ouvertes.fr/hal-00273771

. Sfar, Conference de consensus : Prise en charge des candidoses etaspergilloses invasives de l'adulte, 2004.

R. Gauzit, Y. Cohen, and H. Dupont, Infections by Candida sp. in intensive care. Survey of French practices], Presse Med, vol.32, pp.440-449, 2003.

O. Leroy, J. Mira, and P. Montravers, Candidoses invasives en r??animation??: analyse des traitements antifongiques au cours de l???enqu??te fran??aise AmarCand, Annales Fran??aises d'Anesth??sie et de R??animation, vol.27, issue.12, pp.999-1007, 2008.
DOI : 10.1016/j.annfar.2008.10.004

J. Maertens, O. Marchetti, and R. Herbrecht, European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3???2009 Update, 52. Zilberberg MD, Shorr AF, Kollef MH. Secular trends in candidemia-related hospitalization in the United States, pp.709-727, 2000.
DOI : 10.1086/520980

H. Wisplinghoff, T. Bischoff, and S. Tallent, Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study, Clinical Infectious Diseases, vol.39, issue.3, pp.309-326, 2004.
DOI : 10.1086/421946

M. Mean, O. Marchetti, and C. T. , Bench-to-bedside review: Candida infections in the intensive care unit, Critical Care, vol.12, issue.1, p.204, 2008.
DOI : 10.1186/cc6212

J. Picazo, F. Gonzalez-romo, and F. Candel, Candidemia in the critically ill patient, International Journal of Antimicrobial Agents, vol.32, issue.2, pp.83-88, 2008.
DOI : 10.1016/S0924-8579(08)70005-0

P. Sandven, L. Bevanger, and A. Digranes, Candidemia in Norway (1991 to 2003): Results from a Nationwide Study, Journal of Clinical Microbiology, vol.44, issue.6, pp.1977-81, 1991.
DOI : 10.1128/JCM.00029-06

S. Blot, R. Janssens, and G. Claeys, Effect of fluconazole consumption on long-term trends in candidal ecology, Journal of Antimicrobial Chemotherapy, vol.58, issue.2, pp.474-481, 2006.
DOI : 10.1093/jac/dkl241

O. Marchetti, J. Bille, and U. Fluckiger, Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991???2000, Clinical Infectious Diseases, vol.38, issue.3, pp.311-331, 1991.
DOI : 10.1086/380637

A. Tortorano, J. Peman, and H. Bernhardt, Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study, European Journal of Clinical Microbiology & Infectious Diseases, vol.23, issue.4, pp.317-339, 2004.
DOI : 10.1007/s10096-004-1103-y

A. Colombo, M. Nucci, and B. Park, Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers, Journal of Clinical Microbiology, vol.44, issue.8, pp.2816-2839, 2006.
DOI : 10.1128/JCM.00773-06

M. Pfaller and D. Diekema, Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem, Clinical Microbiology Reviews, vol.20, issue.1, pp.133-63, 2007.
DOI : 10.1128/CMR.00029-06

O. Leroy, J. Gangneux, and P. Montravers, Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005???2006), Critical Care Medicine, vol.37, issue.5, pp.1612-1620, 2005.
DOI : 10.1097/CCM.0b013e31819efac0

URL : https://hal.archives-ouvertes.fr/hal-00676899

G. Martin, D. Mannino, and S. Eaton, The Epidemiology of Sepsis in the United States from 1979 through 2000, New England Journal of Medicine, vol.348, issue.16, pp.1546-54, 1979.
DOI : 10.1056/NEJMoa022139

W. Trick, S. Fridkin, and J. Edwards, Secular Trend of Hospital???Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989???1999, Clinical Infectious Diseases, vol.35, issue.5, pp.627-657, 2002.
DOI : 10.1086/342300

M. Nguyen, J. Peacock, J. Morris, and A. , The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance, The American Journal of Medicine, vol.100, issue.6, pp.617-640, 1996.
DOI : 10.1016/S0002-9343(95)00010-0

G. Dimopoulos, F. Ntziora, and G. Rachiotis, Candida Albicans Versus Non-Albicans Intensive Care Unit-Acquired Bloodstream Infections: Differences in Risk Factors and Outcome, Anesthesia & Analgesia, vol.106, issue.2
DOI : 10.1213/ane.0b013e3181607262

E. Bow, M. Laverdiere, and N. Lussier, Antifungal prophylaxis for severely neutropenic chemotherapy recipients, Cancer, vol.36, issue.Suppl 3, pp.3230-3276, 2002.
DOI : 10.1002/cncr.10610

D. Winston, A. Pakrasi, and R. Busuttil, Prophylactic Fluconazole in Liver Transplant Recipients, Annals of Internal Medicine, vol.131, issue.10, pp.729-766, 1999.
DOI : 10.7326/0003-4819-131-10-199911160-00003

A. Shorr, K. Chung, and W. Jackson, Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis*, Critical Care Medicine, vol.33, issue.9, pp.1928-1963, 2005.
DOI : 10.1097/01.CCM.0000178352.14703.49

B. Sendid, A. Cotteau, and N. Francois, Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links, BMC Infectious Diseases, vol.39, issue.Suppl 1, p.80, 2006.
DOI : 10.1016/S0732-8893(01)00214-0

URL : https://hal.archives-ouvertes.fr/inserm-00080379

D. Abi-said, E. Anaissie, and O. Uzun, The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species, Clinical Infectious Diseases, vol.24, issue.6, pp.1122-1130, 1997.
DOI : 10.1086/513663

E. Playford, A. Webster, and T. Sorrell, Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials, Journal of Antimicrobial Chemotherapy, vol.57, issue.4, pp.628-666, 2006.
DOI : 10.1093/jac/dki491

T. Gleason, A. May, and D. Caparelli, Emerging Evidence of Selection of Fluconazole-Tolerant Fungi in Surgical Intensive Care Units, Archives of Surgery, vol.132, issue.11, pp.1197-201, 1997.
DOI : 10.1001/archsurg.1997.01430350047008

E. Presterl, F. Daxbock, and W. Graninger, Changing pattern of candidaemia 2001???2006 and use of antifungal therapy at the University Hospital of Vienna, Austria, Clinical Microbiology and Infection, vol.13, issue.11, pp.1072-1078, 2007.
DOI : 10.1111/j.1469-0691.2007.01812.x

M. Bassetti, F. Ansaldi, and L. Nicolini, Incidence of candidaemia and relationship with fluconazole use in an intensive care unit, Journal of Antimicrobial Chemotherapy, vol.64, issue.3, pp.625-634, 2009.
DOI : 10.1093/jac/dkp251

M. Lin, Y. Carmeli, and J. Zumsteg, Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control Study, Antimicrobial Agents and Chemotherapy, vol.49, issue.11, pp.4555-60, 2005.
DOI : 10.1128/AAC.49.11.4555-4560.2005

J. Garbino, L. Kolarova, and P. Rohner, Secular Trends of Candidemia Over 12 Years in Adult Patients at a Tertiary Care Hospital, Medicine, vol.81, issue.6, pp.425-458, 2002.
DOI : 10.1097/00005792-200211000-00003

E. Girao, A. Levin, and M. Basso, Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital, Medical Mycology, vol.46, issue.6, pp.581-589, 2008.
DOI : 10.1080/13693780802004996

S. Magill, S. Swoboda, and C. Shields, The Epidemiology of Candida Colonization and Invasive Candidiasis in a Surgical Intensive Care Unit Where Fluconazole Prophylaxis is Utilized, Annals of Surgery, vol.249, issue.4, pp.657-65, 2009.
DOI : 10.1097/SLA.0b013e31819ed914

O. Lortholary, M. Desnos-ollivier, and K. Sitbon, Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients, Antimicrobial Agents and Chemotherapy, vol.55, issue.2, pp.532-540, 2011.
DOI : 10.1128/AAC.01128-10

URL : https://hal.archives-ouvertes.fr/hal-00818523

A. Paugam, M. Baixench, and F. Taieb, Emergence of Candida parapsilosis candidemia at Cochin hospital. Characterization of isolates and search for risk factors, Pathol Biol (Paris), vol.55, issue.2, pp.532-540, 2010.

C. Cheung, Y. Guo, and P. Gialanella, Development of Candidemia on Caspofungin Therapy: a Case Report, Infection, vol.34, issue.6, pp.345-353, 2006.
DOI : 10.1007/s15010-006-5613-7

V. Moudgal, T. Little, and D. Boikov, Multiechinocandin- and Multiazole-Resistant Candida parapsilosis Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis, Antimicrobial Agents and Chemotherapy, vol.49, issue.2, pp.767-776, 2005.
DOI : 10.1128/AAC.49.2.767-769.2005

N. Kabbara, C. Lacroix, P. De-latour, and R. , Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy, Haematologica, vol.93, issue.4, pp.639-679, 2008.
DOI : 10.3324/haematol.11149

G. Forrest, E. Weekes, and J. Johnson, Increasing incidence of Candida parapsilosis candidemia with caspofungin usage, Journal of Infection, vol.56, issue.2, pp.126-135, 2008.
DOI : 10.1016/j.jinf.2007.10.014

M. Bassetti, E. Righi, and A. Costa, Epidemiological trends in nosocomial candidemia in intensive care, BMC Infectious Diseases, vol.33, issue.Suppl, p.21, 2006.
DOI : 10.1097/01.CCM.0000178352.14703.49

J. Wingard, The changing face of invasive fungal infections in hematopoietic cell transplant recipients, Current Opinion in Oncology, vol.17, issue.2, pp.89-92, 2005.
DOI : 10.1097/01.cco.0000152975.65477.7c

A. Tortorano, E. Biraghi, and A. Astolfi, European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region, Journal of Hospital Infection, vol.51, issue.4, pp.297-304, 2002.
DOI : 10.1053/jhin.2002.1261

C. Hung, Y. Chen, and S. Chang, Nosocomial candidemia in a university hospital in Taiwan, J Formos Med Assoc, vol.95, pp.19-28, 1996.

G. Dimopoulos, A. Velegraki, and M. Falagas, A 10-Year Survey of Antifungal Susceptibility of Candidemia Isolates from Intensive Care Unit Patients in Greece, Antimicrobial Agents and Chemotherapy, vol.53, issue.3, pp.1242-1246, 2009.
DOI : 10.1128/AAC.01368-08

L. Ostrosky-zeichner, Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?*, Critical Care Medicine, vol.32, issue.12, pp.2552-2555, 2004.
DOI : 10.1097/01.CCM.0000148226.95597.7E

C. Rieger and H. Ostermann, Empiric vs. preemptive antifungal treatment: an appraisal of treatment strategies in haematological patients, Mycoses, vol.187, issue.s1, pp.31-35, 2008.
DOI : 10.1056/NEJMoa061098

S. Choi, J. Lee, and S. Park, Emergence of Antibiotic Resistance during Therapy for Infections Caused by Enterobacteriaceae Producing AmpC ??-Lactamase: Implications for Antibiotic Use, Antimicrobial Agents and Chemotherapy, vol.52, issue.3, pp.995-1000, 2008.
DOI : 10.1128/AAC.01083-07

A. Muller, J. Lopez-lozano, and X. Bertrand, Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae, Journal of Antimicrobial Chemotherapy, vol.54, issue.1, pp.173-180, 2004.
DOI : 10.1093/jac/dkh282

H. Fricker-hidalgo, B. Lebeau, and H. Pelloux, Use of the BACTEC 9240 System with Mycosis-IC/F Blood Culture Bottles for Detection of Fungemia, Journal of Clinical Microbiology, vol.42, issue.4, pp.1855-1861, 2004.
DOI : 10.1128/JCM.42.4.1855-1856.2004

URL : https://hal.archives-ouvertes.fr/hal-00267403

E. Canton, A. Espinel-ingroff, and J. Peman, Trends in antifungal susceptibility testing using CLSI reference and commercial methods, Expert Review of Anti-infective Therapy, vol.7, issue.1, pp.107-126, 2009.
DOI : 10.1586/14787210.7.1.107

S. Mdo, R. Costa, M. Miranda, and A. , Evaluation of Etest and macrodilution broth method for antifungal susceptibility testing of Candida sp strains isolated from oral cavities of AIDS patients, Rev Inst Med Trop Sao Paulo, vol.44, pp.121-126, 2002.

S. Arikan, Current status of antifungal susceptibility testing methods, Medical Mycology, vol.45, issue.7, pp.569-87, 2007.
DOI : 10.1080/13693780701436794

F. Matsumoto, A. Dias, and M. Melhem, and the AFST???EUCAST microdilution method, Canadian Journal of Microbiology, vol.53, issue.12, pp.1300-1306, 2007.
DOI : 10.1139/W07-095

M. Pfaller, M. Castanheira, and D. Diekema, Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species, Journal of Clinical Microbiology, vol.48, issue.5, pp.1592-1601, 2010.
DOI : 10.1128/JCM.02445-09

D. Monnet, J. Lopez-lozano, and P. Campillos, Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models, Clinical Microbiology and Infection, vol.7, issue.5, pp.29-36, 2001.
DOI : 10.1046/j.1469-0691.2001.00071.x

J. Brocklebank and D. Dickey, SAS for Forecasting Time Series, SAS Publishing, 2003.

C. Hennen, Pharmacoeconomic evaluations of antifungal therapies, Curr Med Res Opin, vol.25, pp.1751-1759, 2009.

S. Silva, M. Negri, and M. Henriques, Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance, FEMS Microbiol Rev, 2011.

M. Pfaller, L. Boyken, and R. Hollis, In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance

M. Pfaller, L. Boyken, and R. Hollis, Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Candida Species to Anidulafungin, Caspofungin, and Micafungin, Journal of Clinical Microbiology, vol.49, issue.2, pp.624-633, 2010.
DOI : 10.1128/JCM.02120-10

M. Pfaller, D. Diekema, and L. Ostrosky-zeichner, Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints, Journal of Clinical Microbiology, vol.46, issue.8, pp.2620-2629, 2008.
DOI : 10.1128/JCM.00566-08

M. Pfaller, L. Boyken, and R. Hollis, In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance, Journal of Clinical Microbiology, vol.44, issue.3, pp.760-763, 2006.
DOI : 10.1128/JCM.44.3.760-763.2006

H. Blumberg, W. Jarvis, and J. Soucie, Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study, Clinical Infectious Diseases, vol.33, issue.2
DOI : 10.1086/321811

P. Pavese, Z. Ouachi, and J. Vittoz, Revue de??pertinence des??prescriptions des??nouveaux antifongiques syst??miques dans??un??h??pital universitaire, M??decine et Maladies Infectieuses, vol.37, pp.223-231, 2007.
DOI : 10.1016/j.medmal.2007.05.009

E. Playford, G. Nimmo, and M. Tilse, Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999???2008, Journal of Hospital Infection, vol.76, issue.1, pp.46-51, 1999.
DOI : 10.1016/j.jhin.2010.01.022

E. Horasan, G. Ersoz, and M. Goksu, Increase in Candida parapsilosis Fungemia in Critical Care Units: A 6-Years Study, Mycopathologia, vol.26, issue.6, pp.263-271, 2010.
DOI : 10.1007/s11046-010-9322-5